Ann Dermatol.  2015 Apr;27(2):228-229. 10.5021/ad.2015.27.2.228.

Oral and Cutaneous Lichenoid Eruption with Nail Changes Due to Imatinib Treatment in a Chinese Patient with Chronic Myeloid Leukemia

• Zhang JA
• Yu JB
• Li XH
• Zhao L

• KMID: 2264823
• DOI: http://doi.org/10.5021/ad.2015.27.2.228

Abstract

No abstract available.

MeSH Terms

Asian Continental Ancestry Group*
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
Lichenoid Eruptions*
Imatinib Mesylate

Reference

1. Deininger MW, O'Brien SG, Ford JM, Druker BJ. Practical management of patients with chronic myeloid leukemia receiving imatinib. J Clin Oncol. 2003; 21:1637–1647.

2. Kuraishi N, Nagai Y, Hasegawa M, Ishikawa O. Lichenoid drug eruption with palmoplantar hyperkeratosis due to imatinib mesylate: a case report and a review of the literature. Acta Derm Venereol. 2010; 90:73–76.

3. Lee JH, Chung JY, Jung MY, Kim CR, Park JH, Park JH, et al. Lichenoid drug eruption after low-dose imatinib mesylate treatment. Ann Dermatol. 2013; 25:500–502.

4. Valeyrie L, Bastuji-Garin S, Revuz J, Bachot N, Wechsler J, Berthaud P, et al. Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: a prospective study of 54 patients. J Am Acad Dermatol. 2003; 48:201–206.

5. Wahiduzzaman M, Pubalan M. Oral and cutaneous lichenoid reaction with nail changes secondary to imatinib: report of a case and literature review. Dermatol Online J. 2008; 14:14.